Biotech research platform


COMPANY SIZE Between 25 and 50

# OF ENGINEERS Between 10 and 25

FUNDING $10M - $25M

TAGS Biotechnology, SaaS, Healthcare, Data Platform, YC Summer 2012


What do we do?

Benchling builds the layer of software that powers life science research. University labs, large pharmaceuticals, and biotech startups alike use Benchling to design, capture, and execute experiments. Our users are curing cancer, engineering organisms, and generally pushing the boundaries of science to solve fundamental problems in society.

Today's cutting-edge research revolves around antiquated systems of paper, email, and Excel - we're building a unified layer of web applications, APIs, and databases to speed up current workflows and enable new ones.

Technical challenges

We're looking for engineers who love building things and care about the impact on the future of research and, by extension, society. We've built: an IDE for DNA, a version of Google Docs for biology, and an API platform to power research automation. You'll build the next arc of our platform, as we expand into broader workflows, new science, and new ways of connecting machines and scientists with the Benchling platform.

Why join us?

Industry: The life science industry is booming. Recent advancements in areas like DNA sequencing and CRISPR / gene engineering have led investors and entrepreneurs alike to declare biotech the next frontier of innovation.

Team: Benchling's founding team came out of MIT, we've hired senior engineering talent from Google and other tech giants, and we're backed by top VCs (YC, Andreessen Horowitz, Thrive Capital). We're uniquely positioned to bring best-in-class engineering and product design to an industry that sorely needs it.

Impact: What you build will directly contribute to critical research. The top CRISPR companies, leading academic institutions, and pharma giants are building their workflows and entire IT stacks on Benchling.

Our press coverage

Our Founders

Sajith Wickramasekara


Founder, Benchling. On leave from MIT CS. Previously did research in personalized cancer therapeutics and nanoparticle drug delivery.

Ashutosh Singhal


Previously staff engineer on Twitter Ads, co-founder of (acq. by Twitter in 2012). BS from MIT EECS and Math, where he did research in optogenetics and functional genomics.

Our tech stack

  • React
  • Python
  • Amazon AWS
  • PostgreSQL
  • Flask

Our investors

  • Thrive Capital
  • Andreessen Horowitz
  • Y Combinator
  • SV Angel